Gene: IDNK
Official Full Name: IDNK gluconokinaseprovided by HGNC
Gene Summary: Predicted to enable gluconokinase activity. Predicted to be involved in D-gluconate catabolic process. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO17026 | IDNK Knockout cell line (HeLa) | Human | IDNK | 1:3~1:6 | Negative | Online Inquiry |
KO17027 | IDNK Knockout cell line (HCT 116) | Human | IDNK | 1:2~1:4 | Negative | Online Inquiry |
KO17028 | IDNK Knockout cell line (HEK293) | Human | IDNK | 1:3~1:6 | Negative | Online Inquiry |
KO17029 | IDNK Knockout cell line (A549) | Human | IDNK | 1:3~1:4 | Negative | Online Inquiry |
IDNK Gene Knockout Cell Lines are genetically engineered cell lines that have had the IDNK gene functionally disrupted through targeted genome editing techniques. These cell lines are invaluable tools for researchers aiming to study the biological implications of IDNK gene loss, including its roles in cellular signaling, metabolic pathways, and disease models. By creating a complete knockout of the IDNK gene, these cell lines allow for detailed analysis of cellular responses and phenotypic changes associated with the absence of this gene.
The key mechanism of action involves the utilization of CRISPR/Cas9 technology, which enables precise cuts in the DNA sequence of the IDNK gene, resulting in frameshifts that lead to nonfunctional protein production. This targeted approach facilitates the investigation of gene function in controlled experiments, allowing for direct observation of the knockout effects on cell behavior, differentiation, and interactions with various stimuli.
The scientific importance of IDNK Gene Knockout Cell Lines extends to both basic research and clinical applications, particularly in understanding diseases where the IDNK gene may play a critical role, such as cancer, metabolic disorders, and neurodegenerative conditions. These cell lines can be used to screen for therapeutic compounds, validate drug targets, and elucidate pathological mechanisms.
Compared to alternative gene-editing technologies or wild-type cell lines, IDNK Gene Knockout Cell Lines provide a more straightforward experimental framework for functional studies. Their specificity and efficiency in gene disruption lead to more reliable and reproducible results in research settings.
For researchers and clinicians, the value of these cell lines lies in their capacity to generate novel insights and accelerate discovery processes in the field of molecular biology and therapeutic development. Utilizing IDNK Gene Knockout Cell Lines empowers scientists to push the boundaries of knowledge, ultimately benefiting the advancement of health care innovations.
Our company specializes in the development and production of high-quality, genetically modified cell lines, leveraging years of expertise in genetic engineering and cell biology. We are committed to supporting your research endeavors with reliable, well-characterized biological products that stand at the forefront of scientific progress.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.